SEC Form 4 research
| Issuer | PIERIS PHARMACEUTICALS, INC. |
|---|---|
| Tickers | PIRS, PVLA |
| Reporting owners | 52 |
| Officers and directors | 12 |
| Last public filing | 2026-10-14 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-14 | 2026-10-13 | JENKINS GEORGE M | S | 1,035 | $131.49 | Not reported |
| 2026-10-14 | 2026-10-13 | JENKINS GEORGE M | S | 990 | $130.48 | Not reported |
| 2026-10-14 | 2026-10-13 | JENKINS GEORGE M | S | 1,644 | $129.23 | Not reported |
| 2026-10-14 | 2026-10-13 | JENKINS GEORGE M | S | 2,004 | $128.52 | Not reported |
| 2026-10-14 | 2026-10-12 | JENKINS GEORGE M | S | 817 | $136.44 | Not reported |
| 2026-10-14 | 2026-10-12 | JENKINS GEORGE M | S | 1,447 | $135.5 | Not reported |
| 2026-10-14 | 2026-10-12 | JENKINS GEORGE M | S | 3,335 | $134.21 | Not reported |
| 2026-10-14 | 2026-10-12 | JENKINS GEORGE M | S | 2,458 | $133.25 | Not reported |
| 2026-10-14 | 2026-10-14 | JENKINS GEORGE M | S | 505 | $126.55 | Not reported |
| 2026-10-14 | 2026-10-14 | JENKINS GEORGE M | S | 597 | $125.33 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.